Aldeyra Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $-54.4M | $1.2M |
| FY2013 | $1.1M | $-40.2M | $3.3M |
| FY2014 | $1.2M | $6.3M | $8.5M |
| FY2015 | $1.2M | $24.9M | $14.6M |
| FY2016 | $1.2M | $24.9M | $14.6M |
| FY2017 | $1.2M | $39.6M | $20.0M |
| FY2018 | — | $86.6M | $47.4M |
| FY2019 | $14.5M | $48.1M | $44.4M |
| FY2020 | $11.4M | $59.5M | $77.9M |
| FY2021 | $15.5M | $205.7M | $229.8M |
| FY2022 | $14.9M | $151.0M | $144.4M |
| FY2023 | $0 | $119.8M | $142.8M |
| FY2024 | $15.0M | $71.0M | $54.5M |
| FY2025 | $0 | $44.3M | $70.0M |